RINDI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 3.576
AS - Asia 2.709
EU - Europa 2.197
SA - Sud America 406
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 9.034
Nazione #
US - Stati Uniti d'America 3.457
SG - Singapore 1.188
CN - Cina 860
UA - Ucraina 464
IE - Irlanda 447
SE - Svezia 354
BR - Brasile 322
FI - Finlandia 319
DE - Germania 245
HK - Hong Kong 243
VN - Vietnam 197
ZA - Sudafrica 111
NL - Olanda 105
CA - Canada 86
GB - Regno Unito 85
IT - Italia 57
TR - Turchia 57
IN - India 51
AR - Argentina 40
RU - Federazione Russa 28
BD - Bangladesh 25
MX - Messico 19
BE - Belgio 17
FR - Francia 15
IQ - Iraq 15
CZ - Repubblica Ceca 13
ES - Italia 12
VE - Venezuela 11
EC - Ecuador 10
JP - Giappone 9
CO - Colombia 8
MA - Marocco 8
PL - Polonia 8
EU - Europa 7
ID - Indonesia 7
JO - Giordania 7
KE - Kenya 7
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CL - Cile 5
IL - Israele 5
PE - Perù 5
PK - Pakistan 5
BG - Bulgaria 4
KZ - Kazakistan 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
EG - Egitto 3
JM - Giamaica 3
KG - Kirghizistan 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SV - El Salvador 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.034
Città #
Singapore 526
Chandler 464
Jacksonville 451
Dublin 446
Santa Clara 338
Ashburn 315
Beijing 259
Dearborn 244
Hong Kong 243
Boardman 163
Nanjing 121
Johannesburg 106
Princeton 100
San Mateo 97
Dallas 80
Ann Arbor 78
Ho Chi Minh City 77
Los Angeles 77
Toronto 69
Wilmington 62
Izmir 50
Helsinki 48
Hanoi 44
Shanghai 33
Nanchang 32
Munich 31
Hebei 30
Pune 30
New York 29
Buffalo 28
Kunming 28
Shenyang 28
Jinan 26
São Paulo 23
Hefei 20
Woodbridge 20
Tianjin 19
Brussels 17
Changsha 15
Guangzhou 15
Moscow 15
Norwalk 12
Haiphong 11
Hangzhou 11
Jiaxing 11
London 11
Columbus 10
Zhengzhou 10
Belo Horizonte 9
Chennai 9
Rio de Janeiro 9
Stockholm 9
Turku 9
Borås 8
Des Moines 8
Parma 8
Amman 7
Auburn Hills 7
Bremen 7
Brno 7
Can Tho 7
Fremont 7
Nairobi 7
Ottawa 7
Redondo Beach 7
Brooklyn 6
Campinas 6
Taiyuan 6
Tashkent 6
Warsaw 6
Baku 5
Da Nang 5
Haikou 5
Hải Dương 5
Prague 5
Rockville 5
Seattle 5
Tokyo 5
Baghdad 4
Brasília 4
Buenos Aires 4
Caracas 4
Casablanca 4
Chicago 4
Curitiba 4
Franca 4
Fuzhou 4
Grafing 4
Guarulhos 4
Joinville 4
Juiz de Fora 4
Marseille 4
Mexico City 4
Ningbo 4
Nova Iguaçu 4
Nuremberg 4
Paris 4
Quảng Ngãi 4
San Francisco 4
Sofia 4
Totale 5.263
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 162
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 141
A high resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications 141
Endocrine tumors of the gastrointestinal system 140
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 138
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 135
A randomised, double-blind, trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over five years 125
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor deficient mice. 124
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 124
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 122
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 120
Consensus guidelines for the management of patients with digestive neuroendocrine tumors: the second event and some final considerations 117
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non small cell lung cancer(NSCLC) and fine needle aspirates from distant metastatic sites. 117
CONSENSUS GUIDELINES ON THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS: WHY SUCH GUIDELINES AND HOW WE WENT ABOUT IT. 116
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 115
Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors 114
Criteria for malignancy in gastrointestinal endocrine tumors 112
Consensus guidelines for the management of patients with digestive neuroendocrine tumors -4- well-differentiated pancreatic tumor/carcinoma: insulinoma. 112
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. 111
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 108
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 107
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS -2- WELL-DIFFERENTIATED DUODENAL TUMOR/CARCINOMA (EXCLUDING GASTRINOMAS). 106
Unusual case of giant typical carcinoid tumor 105
Characterisation of gastric ghrelin cells in man and other mammals – Studies in adult and foetal tissues 104
Classification of the neuroendocrine phenotype in cancer 104
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer 103
Etiology, molecular pathogenesis and genetics 101
Autoimmune gastritis 101
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE ENDOCRINE TUMORS -1- WELL-DIFFERENTIATED GASTRIC TUMORS/CARCINOMAS. 101
Three different synchronous unilateral lung cancers: a case report 101
Optimisation of isolation of richly pure and homogenous primary human colonic smooth muscle cells 99
Classification of neuroendocrine tumours. 99
Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. 98
Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases 98
Anatomia patologica e tumori rari 97
Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract 96
Central Ghrelin gastroprotection involves nitric oxide/prostaglandins cross-talk. 92
Primary mixed adenocarcinoma and small cell carcinoma of the appendix. A clinicopathologic, immunohistochemical and molecular study of a hitherto unreported tumor 90
Ghrelin expression and actions. A novel peptide for an old cell type of the diffuse endocrine system 89
Ghrelin in gastroenteric pathophysiology 89
Linee guida e criteri diagnostici minimi per la diagnosi istologica dei tumori endocrini del tratto gastroenteropancreatico 89
Prognostic value of Goseki histological classification of adenocarcinoma of the cardia 89
Highlights on biology of endocrine tumours of the gut and pancreas 86
GI Tract, General Pathology of Endocrine Growths 85
Endoscopic surgical treatment of pleomorphic adenoma of the inferior nasal turbinate. 85
Sudden onset of colitis after ablation of secretin-expressing lymphocytes in transgenic mice 84
Solitary microcarcinoid of the rectal stump in ulcerative colitis. Case report 84
Il pancreas endocrino. 84
Unusual prostatic carcinoma with endocrine basophilic FSH-immunoreactive cells 83
Mismatch repair system (MMR) status correlates with response and survival in non small cell lung cancer (NSCLC) patients. 83
Peptide YY expression is an early event in intestinal endocrine cell differentiation: evidence from normal and transgenic mice. 83
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinico-pathologic study. 83
Prognostic relevance of a novel TNM-classification system for gastroenteropancreatic neuroendocrine tumors of foregut origin 83
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system 82
The phenotype of gut endocrine tumors 82
Gastrinomas 81
Gastroenteropancreatic neuroendocrine tumours. 80
Epidemiology of carcinoid neoplasm in Vaud, Switzerland, 1974-1997 80
Development of neuroendocrine tumors in the gastro-intestinal tract of transgenic mice: heterogeneity of hormone expression. 80
Transient developmental expression of secretin in serotoninergic neurons of mouse brain 79
PYY-Tag transgenic mice displaying abnormal (H(+)-K(+)ATPase activity and gastric mucosal barrier impairment 79
Targeted ablation of secretin cells reveals a close developmental relationship with CCK and L cells 79
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa 79
A Refractory pleural small cell carcinoma in never smoker. A case report. 79
Introduction to a revised clinicopathological classification of the neuroendocrine tumors of the gastroenteropancreatic tract 78
Insulinoma 78
Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma 78
The ontogeny and tissue specific regulation of ghrelin mRNA expression in the rat strongly indicate that ghrelin is primarily involved in the control of extraendocrine functions 77
Molecular aspects of the endocrine tumors of the pancreas and the gastrointestinal tract 77
Prognostic factors in gastrointestinal endocrine tumors 77
The endocrine pancreas 76
Gastric endocrine cells: types function and growth 76
Pathobiology and classification of digestive endocrine tumors 75
Origin and genetic background of insulinoma 74
Neuroendocrine tumors: history and histopathology 74
Effects of long-term esomeprazole treatment on the gastric mucosa 74
Évaluation de la malignité dans les tumeurs endocrines digestives: recommandations pratiques. 74
Is TCRg clonality assay useful to detect early celiac disease? 73
Gastric neuroendocrine tumors - carcinoid and poorly differentiated carcinoma 73
Histogenesis, diagnosis and molecular basis of the endocrine tumors of the digestive tract and pancreas 73
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. 73
The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumors: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. 73
Dilated intercellular spaces as marker of reflux disease: histology, semiquantitative score and morphometry at light microscopy 72
TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. 72
Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. 71
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database 71
Vesicular monoamine transporter 2 as a marker of gastric ECL cell tumors 70
Endocrine tumours of the gut and pancreas tumor biology and classification 69
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. 69
Ghrelin expression in gut endocrine tumours 68
Effect of CCK-B gastrin receptor blockade on chemically-induced colon carcinogenesis in mice: follow-up at 52 weeks 68
Endocrine and extraendocrine activity of ghrelin and the GHS: basic research 67
Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active ß-catenin. 67
Pathology and biology of gastric neuroendocrine tumors in man 66
The normal endocrine cell of the gut. Changing concepts and new evidences 66
Morphological, molecular, and prognostic aspects of gastric endocrine tumors 60
Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. 58
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells 57
Pancreatic endocrine tumors 54
Dilated intercellular spaces: a major morphological feature of esophagitis. 54
Totale 8.987
Categoria #
all - tutte 30.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 6 97 0 117 10 110 6
2021/2022455 4 1 0 28 17 6 67 97 18 36 63 118
2022/20231.595 197 156 62 129 155 173 15 101 551 10 38 8
2023/2024458 20 71 9 15 41 141 12 16 6 14 38 75
2024/20251.934 19 115 143 60 262 319 32 51 249 217 122 345
2025/20261.958 266 364 329 323 575 101 0 0 0 0 0 0
Totale 9.046